Comment on: "Extended‑Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder"
- PMID: 37656358
- DOI: 10.1007/s40263-023-01034-3
Comment on: "Extended‑Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder"
Comment on
-
Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder.CNS Drugs. 2023 Jul;37(7):655-660. doi: 10.1007/s40263-023-01023-6. Epub 2023 Jul 10. CNS Drugs. 2023. PMID: 37430151 Free PMC article.
References
-
- Price MZ, Price RL. Extended-release viloxazine compared with atomoxetine for attention deficit hyperactivity disorder. CNS Drugs. 2023;37:655–60. https://doi.org/10.1007/s40263-023-01023-6 . - DOI - PubMed - PMC
Publication types
LinkOut - more resources
Full Text Sources
